ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF

Provided herein are activatable antibodies that when activated specifically bind to CD166 and conjugated activatable antibodies that specifically bind to CD166. Also provided are methods of making and using these activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indicat...

Full description

Saved in:
Bibliographic Details
Main Authors KAVANAUGH, W, HUMPHREY, Rachel, TERRETT, Jonathan, CARMAN, Lori, WILL, Matthias, WEAVER, Annie
Format Patent
LanguageEnglish
French
Published 07.05.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are activatable antibodies that when activated specifically bind to CD166 and conjugated activatable antibodies that specifically bind to CD166. Also provided are methods of making and using these activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications. L'invention concerne des anticorps activables qui, une fois activés, se lient spécifiquement au CD166 et des anticorps activables conjugués qui se lient spécifiquement au CD166. L'invention concerne également des procédés de préparation et des méthodes d'utilisation de ces anticorps activables dans diverses indications thérapeutiques, diagnostiques et prophylactiques.
Bibliography:Application Number: WO2019US59363